Latest Content
The 2022 Cytokine Landscape Review
The 2022 Checkpoint Landscape Review
The 2022 ADC Landscape Review
Webinars
DDR Webinar March 2023
Beacon Cancer Vaccine Webinar 2022
DDR Webinar 2022
ADC
The 2022 ADC Landscape Review
ADC: SITC Pre-Conference Planner 2022
ADC: ESMO Post-Conference Report 2022
Adoptive Cell
The 2022 Adoptive Cell Landscape Review
Adoptive Cell: SITC Pre-conference Planner 2022
Adoptive Cell: ESMO Post-Conference Report 2022
Bispecific
The 2022 Bispecific Landscape Review
Bispecific: SITC Pre-Conference Planner 2022
Bispecific: ESMO Post-Conference Report 2022
Checkpoint
The 2022 Checkpoint Landscape Review
Checkpoint: The TIGIT Axis Targeted Cancer Clinical Trial Landscape
Checkpoint: SITC Pre-Conference Planner 2022
Cancer Vaccine
The 2022 Cancer Vaccine Landscape Review
Cancer Vaccine Infographic 2022
Cancer Vaccine: SITC Pre-conference Planner 2022
Cytokine
The 2022 Cytokine Landscape Review
Cytokine: A Spotlight on the TGF-β Cancer Clinical Trial Landscape
Cytokine: SITC Pre-Conference Planner 2022
DDR
DDR Webinar March 2023
The 2022 DDR Landscape Review
DDR ASH Post-Conference Report 2022
Gene Therapy
The 2022 Gene Therapy Landscape Review
Beacon Gene Therapy – The Eye Disorder Landscape
Beacon Gene Therapy – Clinical Holds in the AAV Space
Microbiome
The 2022 Microbiome Landscape Review
Microbiome SITC Post-Conference Report 2022
Microbiome: GI and Metabolic Diseases Infographic
Oncolytic Viruses
The 2022 Oncolytic Viruses Landscape Review
Oncolytic Viruses: SITC Pre-conference Planner 2022
Oncolytic Viruses ESMO Post-Conference Report 2022
RNA
The 2022 RNA Landscape Review
RNA-Targeted Drug Discovery Presentation 2022
RNA SITC Post-Conference Report 2022
TPD
The 2022 TPD Landscape Review
TPD – The Molecular Glue Landscape: A Review
TPD ASH Post-Conference Report 2022
About Beacon
See how our clinical trials and drug database solutions in action
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
